Ticker Symbol: TLIS
Talis Biomedical Corp
$4.76 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001584751
Company Profile
Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginning with COVID-19. The company is developing Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo Park, California.
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3826
Address: N/A
Website: https://talis.bio
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.81
Change:
-$0.02
(
-0.38%)
Days Range: $5.52 - $5.83
Beta: -
52wk. High: $10.50
52wk. Low: $5.04
Ytd. Change -13.11%
50 Day Moving Average: $5.69
200 Day Moving Average: $6.86
Shares Outstanding: 1819038
Valuation
Market Cap: 1.1B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A